FLCNX
Price
$36.42
Change
+$0.35 (+0.97%)
Updated
Jun 12 closing price
Net Assets
37.54B
RGAGX
Price
$86.01
Change
+$0.24 (+0.28%)
Updated
Jun 12 closing price
Net Assets
360.63B
Interact to see
Advertisement

FLCNX vs RGAGX

Header iconFLCNX vs RGAGX Comparison
Open Charts FLCNX vs RGAGXBanner chart's image
FLCNX vs RGAGX Comparison Chart in %
View a ticker or compare two or three
VS
FLCNX vs. RGAGX commentary
Jun 14, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FLCNX is a Hold and RGAGX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RGAGX has more cash in the bank: 361B vs. FLCNX (37.5B). RGAGX pays higher dividends than FLCNX: RGAGX (0.51) vs FLCNX (0.18). FLCNX was incepted earlier than RGAGX: FLCNX (9 years) vs RGAGX (17 years). FLCNX (0.45) is less costly to investors than RGAGX (0.29). FLCNX is a more actively managed with annual turnover of: 37.00 vs. RGAGX (32.00). FLCNX has a lower initial minimum investment than RGAGX: FLCNX (0) vs RGAGX (250). RGAGX annual gain was more profitable for investors over the last year : 8.97 vs. FLCNX (7.66). FLCNX return over 5 years is better than : 75.37 vs. RGAGX (20.11).
FLCNXRGAGXFLCNX / RGAGX
Total Expense Ratio0.450.29155%
Annual Report Gross Expense Ratio0.450.29155%
Fund Existence9 years17 years-
Gain YTD3.0876.75246%
Front LoadN/AN/A-
Min. Initial Investment0250-
Min. Initial Investment IRAN/AN/A-
Net Assets37.5B361B10%
Annual Yield % from dividends0.180.5136%
Returns for 1 year7.668.9785%
Returns for 3 years78.0646.48168%
Returns for 5 years75.3720.11375%
Returns for 10 yearsN/A112.90-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
VGIAX117.71N/A
N/A
Vanguard Growth & Income Adm
FTDZX183.54N/A
N/A
Franklin Biotechnology Discovery Adv
AUUYX26.43N/A
N/A
AB Select US Equity Advisor
RLUSX17.48N/A
N/A
Lazard US Equity Focus R6
JHTCX21.11N/A
N/A
JPMorgan Hedged Equity 3 C